Cargando…

Harmonization of Flow Cytometric Minimal Residual Disease Assessment in Multiple Myeloma in Centers of Polish Myeloma Consortium

Minimal residual disease (MRD) status is now considered as one of the most relevant prognostic factors in multiple myeloma (MM) while MRD negativity became an important endpoint in clinical trials. Here, we report the results of the first study evaluating the reproducibility of high-sensitivity flow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krzywdzińska, Agnieszka, Puła, Bartosz, Czyż, Anna, Krzymieniewska, Beata, Kiernicka-Parulska, Jolanta, Mierzwa, Anna, Szymczak, Donata, Milanowska, Aneta, Kiraga, Aleksandra, Kwiecień, Iwona, Zaleska, Joanna, Jamroziak, Krzysztof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534749/ https://www.ncbi.nlm.nih.gov/pubmed/34679569 http://dx.doi.org/10.3390/diagnostics11101872

Ejemplares similares

Immunophenotypic Characteristics of Bone Marrow Microenvironment Cellular Composition at the Biochemical Progression of Multiple Myeloma
por: Krzywdzińska, Agnieszka, et al.
Publicado: (2022)

Two Doses of BNT162b2 mRNA Vaccine in Patients after Hematopoietic Stem Cell Transplantation: Humoral Response and Serological Conversion Predictors
por: Majcherek, Maciej, et al.
Publicado: (2022)

BCR::ABL1-like acute lymphoblastic leukaemia: a single institution experience on identification of potentially therapeutic targetable cases
por: Płotka, Anna, et al.
Publicado: (2023)

Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2022)

Skin dissemination of myeloma
por: Męcińska-Jundziłł, Kaja, et al.
Publicado: (2017)

The Significance of mRNA in the Biology of Multiple Myeloma and Its Clinical Implications
por: Puła, Anna, et al.
Publicado: (2021)

Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2021)

Flow Cytometric Analysis of Bone Marrow Particle Cells for Measuring Minimal Residual Disease in Multiple Myeloma
por: Jiang, Duanfeng, et al.
Publicado: (2022)

A Stepwise Screening Protocol for Multiple Myeloma
por: Morawska, Marta, et al.
Publicado: (2023)

Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study
por: Kaufman, Jonathan L., et al.
Publicado: (2019)

Sensitive intranuclear flow cytometric quantification of IRF4 protein in multiple myeloma and normal human hematopoietic cells
por: Vora, Ashni A., et al.
Publicado: (2021)

Extracellular Vesicles in Multiple Myeloma—Cracking the Code to a Better Understanding of the Disease
por: Iskrzak, Justyna, et al.
Publicado: (2022)

Advances in diagnostics and therapy of systemic amyloidoses
por: Jamroziak, Krzysztof, et al.
Publicado: (2020)

The International Consortium for Harmonization of Clinical Laboratory Results (ICHCLR) – A Pathway for Harmonization
por: Myers, Gary L., et al.
Publicado: (2016)

Ascites in the Course of Plasma Cell Myeloma Complicated by AL Amyloidosis
por: Debski, Jakub, et al.
Publicado: (2018)

Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma
por: Jakubikova, Jana, et al.
Publicado: (2023)

Bendamustine-Based Regimens as Salvage Therapy in Refractory/Relapsed Multiple Myeloma Patients: A Retrospective Real-Life Analysis by the Polish Myeloma Group
por: Grzasko, Norbert, et al.
Publicado: (2021)

Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells
por: Jeong, Tae-Dong, et al.
Publicado: (2012)

Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma
por: Bartosińska, Joanna, et al.
Publicado: (2021)

The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens
por: Puła, Anna, et al.
Publicado: (2023)

Standardization of flow cytometric minimal residual disease assessment in international clinical trials. A feasibility study from the European Myeloma Network
por: op Bruinink, Davine Hofste, et al.
Publicado: (2020)

Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA
por: Oberle, Anna, et al.
Publicado: (2017)

Insights on Multiple Myeloma Treatment Strategies
por: Mateos, María-Victoria, et al.
Publicado: (2018)

A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis
por: Ríos-Tamayo, Rafael, et al.
Publicado: (2016)

(18)F-fluoro-ethyl-tyrosine ((18)F-FET) PET/CT as a potential new diagnostic tool in multiple myeloma: a preliminary study
por: Czyż, Jarosław, et al.
Publicado: (2019)

Lessons learned about harmonizing survey measures for the CSER consortium
por: Goddard, Katrina A.B., et al.
Publicado: (2020)

Phenotype Harmonization in the GLIDE2 Oral Health Genomics Consortium
por: Divaris, K., et al.
Publicado: (2022)

Solitary Extramedullary Plasmacytoma of the Larynx and Secondary Laryngeal Involvement in Plasma Cell Myeloma: Single-Centre Retrospective Analysis and Systematic Literature Review
por: Szczepanek, Elżbieta, et al.
Publicado: (2022)

Is aggressive treatment of smoldering myeloma the path to curing myeloma?
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023)

Variations in Suppressor Molecule CTLA-4 Gene Are Related to Susceptibility to Multiple Myeloma in a Polish Population
por: Karabon, Lidia, et al.
Publicado: (2011)

Multiple myeloma
por: Collins, Conor D
Publicado: (2004)

The Myeloma Globulins
por: McConnell, R. J., et al.
Publicado: (1958)

The Myeloma Globulins
por: Houghton, P., et al.
Publicado: (1960)

Multiple myeloma
por: Collins, Conor D.
Publicado: (2010)

Multiple Myeloma
por: Mandelli, F
Publicado: (1995)

Multiple Myeloma
por: Shennan, Theodore
Publicado: (1913)

Multiple Myeloma
por: Shennan, Theodore
Publicado: (1913)

Multiple Myeloma
por: Crawford, A. Muir
Publicado: (1933)

Multiple Myeloma
por: Parker, D., et al.
Publicado: (1979)

Multiple Myeloma
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_865njjindjlasmkcbs15q3de44